Literature DB >> 6645122

Immunosuppressive acidic protein (IAP) in gastric cancer patients.

N Shimizu, T Yamane, T Karino, R Hamazoe, Y Osaki, H Kanayama, M Maeta, S Koga.   

Abstract

Immunosuppressive acidic protein (IAP) in the serum from peripheral, splenic and regional venous blood of gastric cancer patients was assayed. Peripheral venous blood was collected before, and for several months after the surgery. The IAP values of peripheral venous blood, increased with advancing cancer stage; in patients at the same cancer stage, the IAP values of venous blood draining from the cancer lesion were the highest. In curatively operated patients, the IAP values increased during the first postoperative month and decreased thereafter. In patients with non-resectable cancer and in patients subjected to palliative surgery, these values remained high; they increased sharply just before death. Determination of the serum IAP values in gastric cancer patients may be useful in estimating the immunological state of gastric cancer patients and for monitoring the postoperative immunological status.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6645122     DOI: 10.1007/BF02469512

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  7 in total

1.  Nonspecific and specific immunosuppression in tumour-bearing mice by soluble immune complexes.

Authors:  R M Gorczynski; D G Kilburn; R A Knight; C Norbury; D C Parker; J B Smith
Journal:  Nature       Date:  1975-03-13       Impact factor: 49.962

2.  Correlation between serum alpha-globulin and plasma inhibitory effect on PHA-stimulated lymphocytes in colon cancer patients.

Authors:  C C Hsu; P LoGerfo
Journal:  Proc Soc Exp Biol Med       Date:  1972-02

3.  Transformation of human lymphocytes: inhibition by homologous alpha globulin.

Authors:  S R Cooperband; H Bondevik; K Schmid; J A Mannick
Journal:  Science       Date:  1968-03-15       Impact factor: 47.728

4.  Immunosuppressive factors in serum of patients with gastric carcinoma.

Authors:  I Urushizaki; K Ishitani; T Nagai; Y Gocho; R Koyama
Journal:  Gan       Date:  1977-08

5.  Elution of "blocking factors" from human tumors, capable of abrogating tumor-cell destruction by specifically immune lymphocytes.

Authors:  H O Sjögren; I Hellström; S C Bansal; G A Warner; K E Hellström
Journal:  Int J Cancer       Date:  1972-03-15       Impact factor: 7.396

6.  Isolation and characterization of an immunosuppressive acidic protein from ascitic fluids of cancer patients.

Authors:  K Tamura; Y Shibata; Y Matsuda; N Ishida
Journal:  Cancer Res       Date:  1981-08       Impact factor: 12.701

7.  Suppression of the immune response by alpha-fetoprotein on the primary and secondary antibody response.

Authors:  R A Murgita; T B Tomasi
Journal:  J Exp Med       Date:  1975-02-01       Impact factor: 14.307

  7 in total
  2 in total

1.  Natural killer activity and serum immunosuppressive acidic protein levels in esophageal and gastric cancers.

Authors:  M Oka; H Mitsunaga; S Hazama; S Yoshino; T Suzuki
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

2.  Elevated alpha1-acid glycoprotein in gastric cancer patients inhibits the anticancer effects of paclitaxel, effects restored by co-administration of erythromycin.

Authors:  Yoshinao Ohbatake; Sachio Fushida; Tomoya Tsukada; Jun Kinoshita; Katsunobu Oyama; Hironori Hayashi; Tomoharu Miyashita; Hidehiro Tajima; Hiroyuki Takamura; Itasu Ninomiya; Masakazu Yashiro; Kousei Hirakawa; Tetsuo Ohta
Journal:  Clin Exp Med       Date:  2015-09-10       Impact factor: 3.984

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.